Description
Survodutide
A research peptide studied as a dual agonist for GLP-1 and glucagon receptors, with protocols focused on appetite reduction, weight management, and metabolic support.
Product Overview
- Peptide: Survodutide
- Strength: 6 mg per vial
- Injection type: Subcutaneous
- Frequency: 1x per week
Reconstitution
Amount in vial: 6 mg
BAC water: 1 mL
Amount per unit: 0.06 mg per unit
Recommended Dose
600 mcg to 4.5 mg
Titrate up from 10 to 75 units
Notes
Subcutaneous injection. Use on the same day every week. Common starting dose: 600 mcg.
Disclaimer
This product is intended for research and informational purposes only.
Reviews
There are no reviews yet.